Related Experiment Videos
Multiple cerebral emboli following dislocation and retraction of a partially deployed CoreValve prosthesis during
Timothy A Fairbairn1, John P Greenwood, Daniel J Blackman
1Multidisciplinary Cardiovascular Research Centres & Leeds Institute of Genetics, Health and Therapeutics, University of Leeds, Leeds, United Kingdom.
Insights
Transcatheter aortic valve implantation improves survival for high-risk patients with severe aortic stenosis. However, stroke risk, often from dislodged atheroma, remains a concern, as illustrated by two case studies.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Medical Device Technology
Background:
- Transcatheter aortic valve implantation (TAVI) offers improved survival for high-operative risk patients with severe aortic stenosis compared to medical therapy.
- Registry data and clinical trials indicate a 3-5% risk of stroke post-TAVI.
Observation:
- Cerebral diffusion-weighted MRI suggests TAVI-associated strokes result from small embolic infarcts, likely from dislodged aortic atheroma.
- The incidence of these subclinical infarcts may exceed clinically apparent strokes.
- Valve repositioning maneuvers during TAVI may increase embolic risk.
Findings:
- This report details two cases of cerebral infarction following TAVI with the Medtronic CoreValve prosthesis.
- Both clinically evident and "silent" cerebral infarcts were observed in these patients.
- The findings highlight potential embolic complications associated with TAVI device manipulation.
Implications:
- Understanding the mechanisms of TAVI-related stroke is crucial for developing preventative strategies.
- Further research is needed to mitigate the risk of cerebral embolism during TAVI procedures.
- These cases underscore the importance of neuroprotection during TAVI in high-risk populations.
Abstract:
Transcatheter aortic valve implantation for patients with severe aortic stenosis at a high-operative risk has been demonstrated to improve mortality compared to standard medical therapy. Registry data and the PARTNER trial have shown a significant risk of stroke (3-5%) following the procedure. Studies using cerebral diffusion-weighted magnetic resonance imaging have suggested the mechanism of stroke to be multiple small embolic infarcts, possibly from aortic atheroma dislodged during the movement of the valve and its apparatus around the thoracic aorta. The incidence of these infarcts is higher than clinically apparent. The Medtronic CoreValve (Medtronic, Minneapolis, Minnesota) prosthesis is a self-expanding nitinol frame with porcine valve, whose deployment is achieved by the retraction of the delivery catheter. Potential complications of this method include valve mal-positioning and dislocation. The partially deployed valve may then be resheathed following retraction back into the descending aorta and subsequently redeployed. We present two such cases with evidence of both "silent" and clinically evident cerebral infarction.
Related Concept Videos
Aneurysm III: Interprofessional Care
Transient Ischemic Attack l: Introduction
Venous Thrombosis I: Introduction
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care